患者体型估算方法用于CMS体型校正剂量报告:变异性、挑战与建议
本研究回顾性分析719例CT检查,评估五种患者直径计算方法对CMS体型校正剂量及达标率的影响,发现不同方法间SAD值存在显著变异,衰减法在胸部检查中高估SAD,投影法在腹部检查中变异更大,协议映射与阈值设定可能影响指标有效性。
要点
- 衰减法(HU阈值、水等效直径)在胸部检查中高估SAD,导致更多不达标。
- 投影法(LAT/AP转换、LAT×AP、(LAT+AP)/2)在腹部检查中变异更大。
- 尿路造影协议SAD值低于CMS阈值30%以上,提示分类或阈值可能错误。
核心结论
- SAD估算方法与协议映射的不一致构成技术挑战,可能削弱该指标的有效性;标准化检查映射与重新审视剂量阈值或可改善与临床实践的一致性并提高CMS指标的可靠性。
研究设计与样本
- 回顾性分析719例CT检查,涵盖7个CT协议(5个腹部、2个胸部),基于CMS措施引用的加州大学旧金山分校示例覆盖不同CT类别,评估五种患者直径计算方法,使用Kruskal-Wallis及成对检验进行统计学比较。
诊断标准与关键数值
- 五种患者直径计算方法:Hounsfield单位阈值法、水等效直径(WED)、横向(LAT)或前后径(AP)转换法、LAT×AP、以及(LAT+AP)/2。
- 衰减法在胸部检查中高估SAD,投影法在腹部检查中变异更大。
- 尿路造影协议SAD值低于CMS阈值30%以上,尽管属高剂量类别。
- 胸部肺栓塞、胸部平扫及尿路造影协议中方法间差异有统计学意义(P < .05)。
临床应用与阅片要点
- 不同SAD估算方法可能导致CMS剂量阈值达标判定出现差异,衰减法在胸部检查中更易出现不达标,投影法在腹部检查中更易出现不达标。
- 尿路造影协议SAD值显著低于CMS阈值,需注意协议分类或阈值设定可能存在错误。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The new CMS1074v3 measure assesses CT size-adjusted dose (SAD) and image quality as part of a reimbursement-linked quality measure. However, a key calculation, patient size estimation, is not strictly defined by CMS, introducing variability that may compromise consistency. This study evaluates five methods for calculating patient size and their impact on SAD and compliance.
METHODS: A retrospective analysis of 719 CT examinations across seven CT protocols was performed. These included five abdomen and two chest protocols covering various CT categories based on University of California San Francisco examples cited in the CMS measure. Five methods for calculating patient diameter were evaluated: Hounsfield unit (HU) Value Thresholding, Water-Equivalent Diameter (WED), Lateral (LAT) or anterior-posterior (AP) Conversion, LAT×AP, and (LAT + AP)/2. Statistical differences were assessed using Kruskal-Wallis and pairwise tests.
RESULTS: SAD values demonstrate significant variability between calculation methods. Attenuation-based methods (HU threshold, WED) overestimated SAD in chest examinations, and projection-based methods showed greater variability in abdominal examinations. This variability affects compliance with CMS-defined dose thresholds, with attenuation-based methods resulting in more failures in chest examinations and projection-based methods in abdominal examinations. The Urogram protocol had SAD values >30% below CMS thresholds despite its high-dose category, suggesting potential error in classification or threshold value. Statistically significant differences (P < .05) were found in Chest pulmonary embolism, Chest without, and Urogram protocols.
CONCLUSIONS: Inconsistencies in SAD estimation methods and protocol mapping pose technical challenges that compromise the effectiveness of the metric. Standardized examination mapping and revisiting dose thresholds may improve alignment with clinical practice and enhance the reliability of the CMS measure.
引用
- Ge G, Weaver CM, Alsalihi A, et al. Patient Size Estimation Methods for CMS Size-Adjusted Dose Reporting: Variability, Challenges, and Recommendations. J Am Coll Radiol. 2025. PMID: 40752757. doi:10.1016/j.jacr.2025.07.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。